Comparison of oral fluid collectors for use in a rapid point-of-care diagnostic device

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 5, 2004, Pages 909-912

  Holm Hansen, Carol ^a   Tong, Gary ^b   Davis, Cheryl ^b   Abrams, William R ^b   Malamud, Daniel ^b,c  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DRUG; NUCLEIC ACID; PROTEIN;

ANTIBODY DETECTION; ARTICLE; BACILLUS CEREUS; BACTERIUM; BODY FLUID; CONTROLLED STUDY; DEVICE; DIAGNOSTIC DEVICE; DIAGNOSTIC TEST; DRUG ANALYSIS; EQUIPMENT; HUMAN; LIQUID; MICROBIOLOGICAL EXAMINATION; MOUTH; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEIC ACID ANALYSIS; ORAL FLUID COLLECTOR; PERFORMANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

DIAGNOSTIC TECHNIQUES AND PROCEDURES; HUMANS; INFECTION; POINT-OF-CARE SYSTEMS; SALIVA; SPECIMEN HANDLING; SUBSTANCE ABUSE DETECTION;

EID: 4644221964     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.5.909-912.2004     Document Type: Article

References (16)

1. Atkinson, J. C., C. Dawes, T. Ericson, P. C. Fox, K. Gandara, D. Malamud, I. D. Mandel, M. Navazesh, and L. A. Tabak. 1993. Guidelines for saliva nomenclature and collection. Ann. N. Y. Acad. Sci. 694:xi-xii.
2. Bellini, W. J., and R. F. Helfand. 2003. The challenges and strategies for laboratory diagnosis of measles in an international setting. J. Infect. Dis. 1879(Suppl. 1):S283-S290.
3. Cone, E. J., L. Presley, M. Lehrer, W. Seiter, M. Smith, K. W. Kardos, E. Fritch, S. Salamone, and R. S. Niedbala. 2002. Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations. J. Anal. Toxicol. 26:541-546.
4. George, R. J. 1997. Future applications of oral fluid specimen technology. In R. Sadovsky (ed.), Oral specimen testing for human immunodeficiency virus. Am. J. Med. 102(Suppl. 4A):21-25.
5. Hodinka, R. L., T. Nagashunmugam, and D. Malamud. 1998. Detection of human immunodeficiency virus antibodies in oral fluids. Clin. Diagn. Lab. Immunol. 5:419-426.
6. Kefalides, P. T. 1999. Saliva research leads to new diagnostic tools and therapeutic options. Ann. Intern. Med. 131:991-992.
7. Lawrence, H. P. 2002. Salivary markers of systemic disease: noninvasive diagnosis of disease and monitoring of general health. J. Can. Dent. Assoc. 68:170-174.
8. Malamud, D., and L. Tabak (ed.). 1993. Ann. N. Y. Acad. Sci., vol. 694. Saliva as a diagnostic fluid. New York Academy of Sciences, New York, N.Y.
9. McKie, A., A. Vyse, and C. Maple. 2002. Novel methods for the detection of microbial antibodies in oral fluid. Lancet Infect. Dis. ii:18-24.
10. Nakashima, K., C. Demeurisse, and G. Cimasoni. 1994. The recovery efficiency of various materials for sampling enzymes and polymorphonuclear leukocytes from gingival crevices. J. Clin. Periodontol. 21:479-483.
11. Sadovsky, R. (ed.). 1997. Oral specimen testing for human immunodeficiency virus. Proceedings of a symposium. Am. J. Med. 102(Suppl. 4A).
12. Slavkin, H. C. 1998. Toward molecularly based diagnostics for the oral cavity. J. Am. Dent. Assoc. 129:1138-1143.
13. Streckfus, C. F., and L. R. Bigler. 2002. Saliva as a diagnostic fluid. Oral Dis. 8:69-76.
14. Tabak, L. A. 2001. A revolution in biomedical assessment: the development of salivary diagnostics. J. Dent. Educ. 65:1335-1339.
15. Van der Eijk, A. A., H. G. Niesters, H. M. Gotz, H. L. Janssen, S. W. Schalm, A. D. Osterhaus, and R. A. de Man. 2004. Paired measurements of quantitative hepatitis B virus DNA in saliva and serum of chronic hepatitis B patients: implications for saliva as infectious agent. J. Clin. Virol; 29:92-94.
16. Walsh, J. M., R. Flegel, D. J. Crouch, L. Cangianelli, and J. Baudys. 2003. An evaluation of rapid point-of-collection oral fluid drug-testing devices. J. Anal. Toxicol. 27:429-439.